Lucie Seyler

Lucie Seyler serves as a Physician in Internal Medicine at the Vitality Research Group of UZB (University Hospital Brussels), affiliated with Vrije Universiteit Brussel. Her clinical and research work centers on infectious disease management within critical care settings, with significant contributions to pandemic response systems and antimicrobial stewardship initiatives across European healthcare networks.

Her research portfolio demonstrates deep expertise in Antimicrobial Resistance, Coronavirus pathogenesis, and Respiratory Tract Infections, particularly through leadership in the EU-funded I-MOVE-COVID-19 surveillance network. Current investigations address diagnostic gaps in Legionnaires' disease and prognostic modeling for severe infections using advanced imaging techniques, reflecting her commitment to bridging clinical practice with public health surveillance.

Recent publications (2024-2025) reveal a strategic focus on pandemic preparedness infrastructure, with emphasis on thoracic CT-based severity prediction for respiratory viruses and European-wide hospital surveillance systems. Her work consistently targets clinically actionable insights for managing difficult-to-treat infections in immunocompromised populations.

Dr. Seyler secured Horizon 2020 funding for the I-MOVE-COVID-19 project (2020-2022), establishing multidisciplinary collaborations across 12 European institutions. She maintains active engagement through 31 recorded scientific activities including conference chairing, workshop leadership, and external academic presentations on antibiotic stewardship and infection control protocols.

As a core member of UZB's Vitality Research Group, she operates within Belgium's national public health framework, contributing to Sciensano (Belgian Institute of Public Health) initiatives while collaborating with European reference laboratories for emerging pathogens.